HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia.

Abstract
A 55-year-old male with chronic lymphocytic leukemia developed a skin eruption after receiving oral cyclophosphamide. Subsequent rechallenge with parenteral cyclophosphamide led to recurrence of the skin lesions, which on biopsy were shown to be vasculitic in nature.
AuthorsR M Green, G J Schapel, R E Sage
JournalAustralian and New Zealand journal of medicine (Aust N Z J Med) Vol. 19 Issue 1 Pg. 55-7 (Feb 1989) ISSN: 0004-8291 [Print] Australia
PMID2764806 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cyclophosphamide
Topics
  • Administration, Oral
  • Chronic Disease
  • Cyclophosphamide (adverse effects, therapeutic use)
  • Humans
  • Leukemia, Lymphoid (drug therapy)
  • Male
  • Middle Aged
  • Vasculitis, Leukocytoclastic, Cutaneous (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: